JPRN-UMIN000029112已完成未知
Efficacy and safety of pyrimethamine/sulfadiazine/folinate combination therapy for the treatment of toxoplasmosis - Efficacy and safety of pyrimethamine/sulfadiazine/folinate for the treatment of toxoplasmosis
niversity of Miyazaki0 个研究点目标入组 122 人开始时间: 2017年9月13日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 122
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. HIV positive patients 2. patients who are allergic to pyrimethamine and/or sulfadiazine 3. patients with megacytic anemia due to folic acid deficiency 4. patients who did not agree to join the study
研究者
相似试验
招募中
2 期
Treatment of congenital toxoplasmosis with pyrimethamine/sulfadiazineCongenital toxoplasmosisJPRN-jRCTs071180093Maruyama Haruhiko35
招募中
2 期
Treatment of disseminated toxoplasmosis/toxoplasma encephalitis with pyrimethamine/sulfadiazineDisseminated toxoplasmosis and toxoplasma encephalitisJPRN-jRCTs071180095Maruyama Haruhiko35
招募中
2 期
Treatment of ocular toxoplasmosis with pyrimethamine/sulfadiazineJPRN-jRCTs071180092Maruyama Haruhiko35
招募中
2 期
Treatment of fetal toxoplasmosis with pyrimethamine/sulfadiazineJPRN-jRCTs071180094Maruyama Haruhiko35
尚未招募
不适用
Efficacy of Sulphadoxine-Pyrimethamine versus Dihydroartemisinin-Piperaquine for Intermittent Preventive Therapy of Pregnancy-associated MalariaMalariaPACTR201701001982152Babcock University350